Total RNA was isolated using the
Zymo Direct-zol RNA MiniPrep Kit (Zymo Research Corp.)
according to the manufacturer’s directions. Cells were treated with 1μM
staurosporine (Sigma-Aldrich) as a positive control. First-strand cDNA was generated using
Superscript III reverse transcriptase (Life Technologies). For quantification of cellular
markers of toxicity/apoptosis, real-time PCR was performed using commercially validated
TaqMan-based primer-probe sets (
table S1) and
TaqMan Universal PCR Mix (Life
Technologies). Results were then normalized as described above.
Sheahan T.P., Sims A.C., Zhou S., Graham R.L., Pruijssers A.J., Agostini M.L., Leist S.R., Schäfer A., Dinnon KH I.I.I., Stevens L.J., Chappell J.D., Lu X., Hughes T.M., George A.S., Hill C.S., Montgomery S.A., Brown A.J., Bluemling G.R., Natchus M.G., Saindane M., Kolykhalov A.A., Painter G., Harcourt J., Tamin A., Thornburg N.J., Swanstrom R., Denison M.R, & Baric R.S. (2020). An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Science Translational Medicine.